ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/01/2023
Back to search
Official data from USPTO
MULTI-TARGET THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MULTI-TARGET THERAPEUTICS
ST13
US500000090452252Class
42
Filing
90452252
Registration
6592165
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
11/01/2023
Trademark type
Word
Nice classes
42
Filing date
01/07/2021
Registration date
12/14/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/14/2021
Last transaction
12/14/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
06/30/2021
First use in commerce
06/30/2021
Drawing code
4
Owner type
03
Owner location
ANNAPOLIS, MD
Examiner
JENKINS JR, CHARLES
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ALPHYN BIOLOGICS, INC.
Alphyn Biologics, LLC
Representatives
Michael J. Hertz Woods Rogers Vandeventer Black PLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development of drugs and medicines for the treatment of infectionslung diseasesskin diseases; Research and development in the pharmaceuticallife sciencesbiomedicine fields; Scientific researchtestinganalysis in the fields of pharmaceuticalslife sciencebiomedicine; Medical and scientific research on lung diseasesskin diseasesinfectionscancer; Pharmaceutical products testinganalysisresearchdevelopment
Publications
History of USPTO decisions and trademark events.
26 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/18/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/18/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/18/2022
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
12/14/2021
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/10/2021
ALIE
ASSIGNED TO LIE
11/08/2021
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
11/06/2021
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
11/05/2021
IUAA
USE AMENDMENT ACCEPTED
11/05/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
11/03/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/03/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
11/03/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/03/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/29/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/28/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/28/2021
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
09/16/2021
IUAF
USE AMENDMENT FILED
09/16/2021
EAAU
TEAS AMENDMENT OF USE RECEIVED
09/15/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/12/2021
GNRT
NON-FINAL ACTION E-MAILED
07/12/2021
CNRT
NON-FINAL ACTION WRITTEN
07/12/2021
DOCK
ASSIGNED TO EXAMINER
06/30/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/06/2021
NWAP
NEW APPLICATION ENTERED
01/11/2021
Continuous trademark protection
Get notified about every new filing that threatens MULTI-TARGET THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.